Insider · CIK 0001203240
John McLaughlin
Files at SNOA (Sonoma Pharmaceuticals, Inc.). First filing -, latest -.
In brief
John McLaughlin files SEC Form 4 as director at SNOA (Sonoma Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John McLaughlin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | SNOA Sonoma Pharmaceuticals, Inc. | AGrant or award Stock option (right to buy)derivative | +10,000 | - | - | 30,001 | Jul 9, 2026 |
| Jan 2, 2026 | SNOA Sonoma Pharmaceuticals, Inc. | AGrant or award Stock option (right to buy)derivative | +10,000 | - | - | 20,001 | Jan 2, 2026 |
Questions about John McLaughlin
Answered from the filings on this page, as of the latest one.
Is John McLaughlin buying or selling?
John McLaughlin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John McLaughlin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John McLaughlin has 0.
Where does John McLaughlin file Form 4?
John McLaughlin has filed Form 4 at SNOA (Sonoma Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.